|X Technologies, Inc. announced that the FX miniRAIL(TM) Coronary Dilatation Catheter was showcased this week at the Joint Interventional Meeting (JIM) in Rome, Italy. Eight clinical cases were televised from Columbus Hospital Center, Milan Italy and Heart Center, Siegburg Germany to a live audience of over 500 international participants in both Rome and Washington, DC.
These cases included: in-stent restenosis, de novo lesions, bypass grafts and vessel preparation for investigational drug-coated stents.
X Technologies received CE Mark Approval for the FX miniRAIL(TM) Coronary Dilatation Catheter in December 2001. The catheter is available throughout Europe. The company also supports a 265 patient IDE study in the United States.
The FX miniRAIL is a low profile, 6F compatible system that integrates two flexible stainless steel wires adjacent to the dilatation balloon. These wires focus the balloon’s dilatation force to create two longitudinal expansion planes in the coronary plaque and stabilize the balloon across the target lesion. The device has a short, 12mm guide wire exit port that facilitates rapid, single operator exchanges.
X Technologies is a privately held Corporation established in 1999. The company was founded and is managed by a highly experienced, multinational team of medical, engineering and business professionals from within the Cardiovascular Industry. This team develops, manufactures and markets innovative products for angioplasty providing less invasive therapy for a broad range of circulatory diseases.